Drug-drug interaction with two different route of administration [Design Issues]

posted by dshah  – India/United Kingdom, 2022-07-21 20:51 (730 d 16:28 ago) – Posting: # 23156
Views: 2,211

Dear Rao!
Kindly see the below articles which might help you.
  1. No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone. Eur Respir J . 2019 Jan 10;53(1):1801060. doi: 10.1183/13993003.01060-2018.
  2. Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. Pharmaceuticals (Basel). 2021 Aug; 14(8): 819.
  3. Clinical biopharmaceutics review.
They might help you to proceed further.

Regards,
Divyen Shah

Complete thread:

UA Flag
Activity
 Admin contact
23,112 posts in 4,858 threads, 1,644 registered users;
63 visitors (0 registered, 63 guests [including 20 identified bots]).
Forum time: 13:20 CEST (Europe/Vienna)

It’s always fun to have your models validated,
but is way more fun to have them trashed.
Finding out you are completely wrong
is a great part of science.    G. Randall Gladstone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5